研究报告 |
|
|
|
|
猪髓样分化因子MyD88特异性shRNA干扰载体的构建筛选及干扰效果评价 |
宗鑫, 胡汪洋, 汪以真 |
浙江大学饲料科学研究所 农业部动物营养与饲料重点开放实验室 浙江省饲料及动物营养重点实验室 杭州 310029 |
|
Construction and Evaluation of Porcine Myeloid Differentiation Factor 88(MyD88) shRNA Interference Vector |
ZONG Xin, HU Wang-yang, WANG Yi-zhen |
Institute of Food Science, Ministry of Agriculture Key Laboratory of Animal Nutrition and Feed Science, Zhejiang Provincial Laboratory of Feed and Animal Nutrition, Zhejiang University, Hangzhou 310029, China |
[1] 方丽娟, 孟民杰. 髓样分化因子88研究进展. 广东药学院学报,2011,27(2):215-217. Fang L J, Meng M J. Progress in the study of myeloid differentiation factor 88. Journal of Guangdong Pharmaceutical College, 2011, 27(2): 215-217.
[2] Sheedy F J, O'Neill L A J. The troll in toll: Mal and TRAM as bridges for TLR2 and TLR4 signaling. J Leukocyte Biol, 2007, 82(1): 196-203.
[3] Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol, 2004,4(2):499-511.
[4] 吴燕燕, 王易. Toll样受体信号通路中MyD88的研究进展. 免疫学杂志.,2012,28(3):262-265. Wu Y Y, Wang Y. The progress in the MyD88-dependent receptor signaling pathway. Immunological Journal, 2012, 28(3): 262-265.
[5] Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science, 2010, 327(3): 291-295.
[6] Casanova J L, Abel L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annual Review of Immunology, 2011, 29(3):447-491.
[7] Li X X, Qin J Z. Modulation of Toll-interleukin 1 receptor mediated signaling. J Mol Med, 2005, 83(3):258-266.
[8] Taniguchi Y, Yoshioka N. Mechanism for maintaining homeostasis in the immune system of the intestine. Anticancer Research, 2009, 29(4):4855-4860.
[9] Zhu J, Mohan C. Toll-like receptor signaling pathways-therapeutic opportunities. Mediators of Inflammation, 2010, 78(12):35-37.
[10] 梁小明, 陈昌辉. 髓样分化因子88在Toll样受体信号通路中的作用及临床意义. 实用儿科临床杂志,2012,27(15):1197-1200. Liang X M, Chen C H. Role and clinical significance of myeloid differentiation factor 88 in Toll-like receptor mediated signaling transduction. Journal of Applied Clinical Pediatrics, 2012, 27(15):1197-1200.
[11] Tabeta K, Georgel P, Janssen E, et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. PNAS, 2004, 101(5):3516-3521.
[12] An H, Qian C, Cao X. Regulation of Toll-like receptor signaling in the innate immunity. Science China-Life Sciences, 2010,53(6):34-43.
[13] Jin B, Sun T, Yu X H, et al. The effects of TLR activation on T-cell development and differentiation. Clinical & Developmental Immunology, 2012,48(3):778-786.
[14] Kawai T, Akira S. TLR signaling. Semin Immunol, 2007, 19(2):24-32.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|